lutetium (177Lu) vipivotide tetraxetan (Pluvicto) Report issue

Small molecule Approved FDA First in Class Breakthrough Therapy FDA Priority Review FDA

Back

Chemistry

Mol. Mass

1216.07

ALogP

Missing data

Rule of 5

Missing data

Rule of 3

Missing data
Details

Sources

CHEMBL4594406   ChEMBL
lutetium lu 177 vipivotide tetraxetan

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue